CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-013696
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 PCI domain-containing protein 2 
Protein Synonyms/Alias
 CSN12-like protein 
Gene Name
 PCID2 
Gene Synonyms/Alias
 HT004 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
32CAELVSFKHPHVANPubiquitination[1]
49QMASPEEKCQQVLEPubiquitination[1]
182NADQQLVKKGKSKVGubiquitination[1, 2]
187LVKKGKSKVGDMLEKubiquitination[1]
255AIDSSNLKDDYSTAQubiquitination[1, 2, 3]
267TAQRVTYKYYVGRKAubiquitination[1, 2, 3]
273YKYYVGRKAMFDSDFubiquitination[1]
442HQKLVVSKQNPFPPLubiquitination[1, 2]
Reference
 [1] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
 Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
 Mol Cell Proteomics. 2013 Mar;12(3):825-31. [PMID: 23266961]
 [2] Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.
 Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA.
 Mol Cell Proteomics. 2012 May;11(5):148-59. [PMID: 22505724]
 [3] hCKSAAP_UbSite: improved prediction of human ubiquitination sites by exploiting amino acid pattern and properties.
 Chen Z, Zhou Y, Song J, Zhang Z.
 Biochim Biophys Acta. 2013 Aug;1834(8):1461-7. [PMID: 23603789
Functional Description
 Required for B-cell survival through the regulation of the expression of cell-cycle checkpoint MAD2L1 protein during B cell differentiation (By similarity). 
Sequence Annotation
 DOMAIN 277 388 PCI.
 MOD_RES 2 2 N-acetylalanine.  
Keyword
 3D-structure; Acetylation; Alternative splicing; Complete proteome; Direct protein sequencing; Reference proteome. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 399 AA 
Protein Sequence
MAHITINQYL QQVYEAIDSR DGASCAELVS FKHPHVANPR LQMASPEEKC QQVLEPPYDE 60
MFAAHLRCTY AVGNHDFIEA YKCQTVIVQY PLSFMAAVPH RTHAVDYLGL ETRKHWASCS 120
FLQLERNDSV LEQKLVSALS LGTSFLRAFQ AHKEENWALP VMYAVALDLR VFANNADQQL 180
VKKGKSKVGD MLEKAAELLM SCFRVCASDT RAGIEDSKKW GMLFLVNQLF KIYFKINKLH 240
LCKPLIRAID SSNLKDDYST AQRVTYKYYV GRKAMFDSDF KQAEEYLSFA FEHCHRSSQK 300
NKRMILIYLL PVKMLLGHMP TVELLKKYHL MQFAEVTRAV SEGNLLLLHE ALAKHEAFFI 360
RCGIFLILEK LKIITYRNLF KKVYLLLKTH QLSLDAFLVA LKFMQVEDVD IDEVQCILAN 420
LIYMGHVKGY ISHQHQKLVV SKQNPFPPLS TVC 453 
Gene Ontology
 GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
 GO:2000117; P:negative regulation of cysteine-type endopeptidase activity; IMP:UniProtKB.
 GO:0045579; P:positive regulation of B cell differentiation; IEA:Compara.
 GO:0090267; P:positive regulation of mitotic cell cycle spindle assembly checkpoint; IMP:UniProtKB.
 GO:0045893; P:positive regulation of transcription, DNA-dependent; IMP:UniProtKB.
 GO:0043488; P:regulation of mRNA stability; IMP:UniProtKB.
 GO:0048536; P:spleen development; ISS:UniProtKB. 
Interpro
 IPR013143; PAM.
 IPR000717; PCI_dom. 
Pfam
 PF01399; PCI 
SMART
 SM00753; PAM 
PROSITE
  
PRINTS